Articles tagged with “Galvmed”
The Pirbright Institute, through the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) has entered into a new agreement with GALVmed to develop and deploy a safer and more effective Rift Valley fever (RVF) vaccine for use in low- and middle-income countries, particularly across Africa. The partnership builds on a longstanding relationship between Pirbright and GALVmed, combining CVIM’s expertise […]
